Time intervals to care and health service use experiences of uninsured cancer patients treated under public financing in Mexico City
K Unger-Saldaña, A Arroyo-Valerio, GS Turrubiates… - Cancer …, 2023 - Elsevier
Background The present study assesses the time intervals from symptom discovery to
treatment start and describes the health service use experiences of uninsured patients with …
treatment start and describes the health service use experiences of uninsured patients with …
De vuelta a la clínica. Métodos I. Diseños de investigación. Mayor calidad de información, mayor certeza a la respuesta
JO Talavera, I Roy-García, L Palacios-Cruz… - Gaceta médica de …, 2019 - medigraphic.com
Los diseños de investigación se refieren a la forma como se obtiene la información y están
limitados por viabilidad ética, económica y temporal. Son estrategias estandarizadas para …
limitados por viabilidad ética, económica y temporal. Son estrategias estandarizadas para …
Comprehensive omic characterization of breast cancer in Mexican-Hispanic women
SL Romero-Cordoba, I Salido-Guadarrama… - Nature …, 2021 - nature.com
Breast cancer is a heterogeneous pathology, but the genomic basis of its variability remains
poorly understood in populations other than Caucasians. Here, through DNA and RNA …
poorly understood in populations other than Caucasians. Here, through DNA and RNA …
Mitochondrial DNA mutation analysis in breast cancer: shifting from germline heteroplasmy toward homoplasmy in tumors
CJ Pérez-Amado, H Tovar, L Gómez-Romero… - Frontiers in …, 2020 - frontiersin.org
Studies have suggested a potential role of somatic mitochondrial mutations in cancer
development. To analyze the landscape of somatic mitochondrial mutation in breast cancer …
development. To analyze the landscape of somatic mitochondrial mutation in breast cancer …
Biological landscape of triple negative breast cancers expressing CTLA-4
MGC Navarrete-Bernal, MG Cervantes-Badillo… - Frontiers in …, 2020 - frontiersin.org
Patients with triple-negative breast cancer (TNBC) have a poor prognosis, partly because of
the absence of targeted therapies. Recognition of the key role of immune responses against …
the absence of targeted therapies. Recognition of the key role of immune responses against …
Breast cancer survival in Mexico between 2007 and 2016 in women without social security: a retrospective cohort study
K Unger-Saldaña, A Bandala-Jacques… - The Lancet Regional …, 2023 - thelancet.com
Background Essential indicators of health system performance for breast cancer are lacking
in Mexico. We estimated survival and clinical stage distribution for women without social …
in Mexico. We estimated survival and clinical stage distribution for women without social …
Building capacity for global cancer research: existing opportunities and future directions
S Sivaram, S Perkins, M He, E Ginsburg… - Journal of Cancer …, 2021 - Springer
Cancer incidence and mortality are increasing in low-and middle-income countries (LMICs),
where more than 75% of global cancer burden will occur by the year 2040. The primary …
where more than 75% of global cancer burden will occur by the year 2040. The primary …
Financial toxicity among older mexican adults with cancer and their families: A mixed-methods study
S Sánchez-Román, Y Chavarri-Guerra… - JCO Global …, 2022 - ascopubs.org
PURPOSE The financial toxicity (FT) of cancer is common among older adults in high-
income countries, but little is known about the financial hardships faced by older patients …
income countries, but little is known about the financial hardships faced by older patients …
Impact of invasive lobular carcinoma on long-term outcomes in Mexican breast cancer patients
D Flores-Díaz, C Arce, L Flores-Luna… - Breast cancer research …, 2019 - Springer
Purpose The aim of this study was to compare the difference in disease-free survival (DFS)
and overall survival (OS) between invasive lobular carcinoma (ILC) and invasive ductal …
and overall survival (OS) between invasive lobular carcinoma (ILC) and invasive ductal …
[HTML][HTML] Asociando factores pronósticos con resultados clínicos en cáncer de mama localmente avanzado
N Ramírez-Torres, A Reyes-López… - Revista Médica del …, 2023 - ncbi.nlm.nih.gov
Objetivo: identificar marcadores clínico-patológicos y moleculares como predictores de la
supervivencia en pacientes con cáncer de mama localmente avanzado (CMLA). Material y …
supervivencia en pacientes con cáncer de mama localmente avanzado (CMLA). Material y …